NIC Advocating for better high-speed broadband service

The Board of Directors of the Norfolk Innovation Corridor is advocating for better high-speed broadband service in the Corridor at nationally competitive rates.  The following letter was sent to Mayor Kenny Alexander, City Manager Chip Filer, and leadership at Cox Cable and MetroNet.

If you or your business would like to help support this effort, please email Linda Peck at

Norfolk Innovation Corridor Appoints Linda Peck as Its First Executive Director

Graphical user interface

Description automatically generated with low confidence

NORFOLK, VA – (July 13, 2021) – Norfolk Innovation Corridor (NIC) announced the appointment of Norfolk native Linda Peck as its first executive director.

A public-private partnership, the recently launched Norfolk Innovation Corridor (NIC) will develop and attract technology businesses along with entrepreneurs and innovators specializing in resilience technologies, products and services, whether combating sea level rise and recurrent flooding, cybersecurity perils, supply chain/logistics disruptions, population and behavioral health crises, or other threats to the optimal functioning of our communities, businesses and infrastructure.

“Linda is a connector, putting people together to move this community forward,” said Charles V. McPhillips, who as former president of Greater Norfolk Corporation drove the creation of the NIC. “The future of the NIC is a high priority for the civic, business, governmental and academic leaders in this community. Linda has a proven track record in developing and executing strategic plans to advance such an ambitious mission. We’re excited to have her lead the NIC, working closely with an outstanding board of directors.”

Dan Peterson, president of the NIC, added, “As the NIC continues to gain speed and momentum, we are extremely grateful to have Linda at the helm to lead us through the next steps to our future successes.” 

“I’m thrilled to be a part of this exciting and important initiative. The NIC’s mission not only speaks to my heart, but also offers me the opportunity to give back to the community that I deeply care about,” Peck said.

Peck obtained a bachelor’s degree from the University of Pennsylvania and a MBA in finance from Columbia Business School. After starting her career in corporate and foundation fundraising, she worked in corporate finance at GE Capital in Manhattan, taught middle and high school education and spent the last 15 years in nonprofit leadership, most recently as the executive director of Ohef Sholom Temple in Norfolk.

APRIL 28, 2021 ReAlta Life Sciences Closes $20 Million Series A3 Financing to Advance Multiple Programs into Phase 2 Clinical Trials

Norfolk, VA, April 28, 2021 — ReAlta Life Sciences, Inc., today announced that the Company has successfully closed a Series A3 financing of $20 million. The financing was led by Marathon Pharma, with support from existing Series A investors and new, undisclosed investors. Funding obtained in this financing will advance multiple programs addressing ALI and HIE, including lead candidate RLS-0071, into Phase 2 clinical trials.

“The additional capital raised will support the advancement of our lead candidate, RLS-0071, into Phase 2 programs for multiple indications,” said Ulrich Thienel, M.D., Ph.D., ReAlta’s Chief Executive Officer. “This funding also allows us to bring our second compound into clinical development and leverage its unique capabilities to address new life-threatening medical needs. We appreciate our investors’ continued confidence in our platform and pipeline.”

ReAlta is advancing a new class of anti-inflammatory therapies based on its EPICC platform that leverages a billion years of evolution with a dual targeting mechanism that inhibits components of the complement cascade and cellular inflammatory processes. The Company’s lead compound RLS-0071 is in development to address hospital-based acute inflammatory conditions, including acute lung injury (ALI) and severe birth asphyxia or hypoxic ischemic encephalopathy (HIE), that could respond to the compound’s swift, powerful inhibition of complement and neutrophil recruitment and activation. ReAlta is currently conducting a Phase 1 trial in healthy volunteers for RLS-0071, as well as a separate proof of concept study to evaluate RLS-0071 as a therapy for ALI in hospitalized COVID-19 subjects. In addition, ReAlta is advancing the second compound emerging from its proprietary EPICC technology platform, RLS-0088, through IND-enabling studies later this year.

About ReAlta Life Sciences

ReAlta Life Sciences, Inc. is a clinical stage biotech company dedicated to harnessing the power of the immune system through its EPICC technology platform, comprised of a family of over 160 engineered peptides, to address life-threatening medical needs. The peptide family leverages one billion years of evolution that has enabled the human astrovirus to inhibit components of the innate immune system. This novel class of therapeutics exploits the virus’ dual targeting approach and enables the rebalancing of complement and inflammatory processes in the body. The company’s pipeline is led by RLS-0071, which has been granted Orphan Drug Designation by the U.S. Food and Drug Administration and European Medicines Agency for the treatment of hypoxic-ischemic encephalopathy (HIE) in neonates. The company launched in 2018, and is located in Norfolk, Virginia. For more information, please visit

Norfolk Innovation Corridor Launches New Technology Zone to Attract Start-up Companies, Skilled Talent & Catalyze Growth

The coastal city of Norfolk, Virginia, known globally for its expertise in resilience and strong entrepreneurship ecosystem, is emerging as a tech hub for companies supporting products, technologies and services in the resilience sector.

Today, Daniel Peterson announced the launch of the Norfolk Innovation Corridor (NIC), an area paralleling the Elizabeth River Trail designated as a “technology zone” to attract and retain qualifying start-ups and firm expansions through tax incentives. With more than 55,000 college students graduating from Norfolk colleges and universities every year and access to R&D from anchor academic and health institutions, the zone also serves as a magnet for a high-tech, talented and diverse workforce.

“Civic and business leaders in Norfolk are prepared to do our part in reviving our region’s economy and making it work for everyone,” said Charles V. McPhillips, past president of Greater Norfolk Corporation.

The new Norfolk Innovation Corridor will support tech companies specializing in combatting sea level rise and recurrent flooding, green technologies, cybersecurity, supply chain and maritime logistics, population health threats, behavioral health crisis, bioinformatics, advanced transportation technologies and more.

“Anchor academic, research and health institutions clustered close to tech start-ups give Norfolk a strong competitive edge, as entrepreneurs and researchers collaborate to advance the region’s leadership in innovation and economic development,” said Mayor Kenneth Cooper Alexander.

One of the first start-ups that established itself along the corridor, 3DXtremes, combines 3D printing with augmented reality to help inventors and organizations turn their napkin-sketch concepts into real products ready for market. The company was founded by Old Dominion University graduate and tech entrepreneur Blade Taylor.

ReAlta Life Sciences, created by physicians and researchers affiliated with corridor anchors EVMS and CHKD, recently closed on a $26 million series A2 equity financing. The firm advances bio-tech therapies for the treatment of hypoxic ischemic encephalopathy (HIE), a severe birth complication affecting newborns suffering from oxygen deprivation to the brain. It is also exploring treatments for other inflammatory disorders, such as the “cytokine storm” associated with COVID-19.

According to Peterson, who is chairman of the NIC, these vital collaborations deepen the pools of talent, technology spin-offs and supply chain support that can fuel our version of the innovation districts that have catalyzed economic growth in metropolitan areas ranging from Austin, to Chattanooga, to Philadelphia, to Boston and beyond.

“In the midst of one of the worst global pandemics in history, the launch of the Norfolk Innovation Corridor is a strong example of the resilience shown by anchor institutions and other economic, physical and networking assets concentrated in the Corridor, which today open doors to new opportunities,” he said.